IN VIVO EVALUATION OF THE FENAWAL SEPACELL R200 AND R350 FILTER SYSTEM

FENAWAL SEPACELL R200 和 R350 过滤系统的体内评估

• 批准号: 3787973
• 负责人: KENNETH D FRIEDMAN
• 金额: --
• 依托单位: UNIVERSITY OF NEW MEXICO
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3787973
• 关键词: blood donor; blood filtration; blood preservation; blood transfusion; blood treatment; erythrocytes; human subject

The purpose of this project is to test in vivo viability of red cells stored for 42 days after filtration to remove white cells. The filtration of red cells to remove both lymphocytes and neutrophils from the stored red cell is usually done at the bedside. The technology is to remove the white cells shortly after the unit is donated. It is hoped that by removing neutrophils and lymphocytes before storage there will be a reduced potential for alloimmunization of transfusion recipients.

本项目的目的是测试红细胞的体内活力 过滤除去白色细胞后储存42天。 的 过滤红细胞，以去除淋巴细胞和中性粒细胞， 储存的红细胞通常在床边进行。 该技术 以在捐赠单位后不久去除白色细胞。 是 希望通过在储存前去除中性粒细胞和淋巴细胞， 将降低输血同种免疫的可能性 受惠人士